MRC Biostatistics Unit, University of Cambridge, Cambridge, United Kingdom.
National Heart and Lung Institute, Imperial College London, London, United Kingdom.
PLoS One. 2020 Jul 21;15(7):e0236011. doi: 10.1371/journal.pone.0236011. eCollection 2020.
Accurate prognosis information after a diagnosis of chronic obstructive pulmonary disease (COPD) would facilitate earlier and better informed decisions about the use of prevention strategies and advanced care plans. We therefore aimed to develop and validate an accurate prognosis model for incident COPD cases using only information present in general practitioner (GP) records at the point of diagnosis. Incident COPD patients between 2004-2012 over the age of 35 were studied using records from 396 general practices in England. We developed a model to predict all-cause five-year mortality at the point of COPD diagnosis, using 47,964 English patients. Our model uses age, gender, smoking status, body mass index, forced expiratory volume in 1-second (FEV1) % predicted and 16 co-morbidities (the same number as the Charlson Co-morbidity Index). The performance of our chosen model was validated in all countries of the UK (N = 48,304). Our model performed well, and performed consistently in validation data. The validation area under the curves in each country varied between 0.783-0.809 and the calibration slopes between 0.911-1.04. Our model performed better in this context than models based on the Charlson Co-morbidity Index or Cambridge Multimorbidity Score. We have developed and validated a model that outperforms general multimorbidity scores at predicting five-year mortality after COPD diagnosis. Our model includes only data routinely collected before COPD diagnosis, allowing it to be readily translated into clinical practice, and has been made available through an online risk calculator (https://skiddle.shinyapps.io/incidentcopdsurvival/).
准确的慢性阻塞性肺疾病(COPD)诊断预后信息将有助于更早、更明智地决定使用预防策略和高级护理计划。因此,我们旨在仅使用诊断时全科医生(GP)记录中的信息,为新发 COPD 病例开发和验证一种准确的预后模型。我们研究了 2004 年至 2012 年间年龄在 35 岁以上的 396 家英格兰全科诊所的新发 COPD 患者。我们使用了 47964 名英国患者的数据,开发了一种预测 COPD 诊断时全因五年死亡率的模型。我们的模型使用年龄、性别、吸烟状况、体重指数、1 秒用力呼气量(FEV1)占预计值的百分比和 16 种合并症(与 Charlson 合并症指数相同数量)。我们选择的模型在英国所有国家(N=48304)的数据中进行了验证。我们的模型表现良好,在验证数据中表现一致。每个国家的验证曲线下面积在 0.783-0.809 之间,校准斜率在 0.911-1.04 之间。与基于 Charlson 合并症指数或剑桥多重合并症评分的模型相比,我们的模型在这种情况下表现更好。我们开发并验证了一种模型,该模型在预测 COPD 诊断后五年死亡率方面优于一般多重合并症评分。我们的模型仅包含在 COPD 诊断前常规收集的数据,允许它很容易转化为临床实践,并通过在线风险计算器(https://skiddle.shinyapps.io/incidentcopdsurvival/)提供。